Chad Pecot, MD, and colleagues have developed a “two-in-one” molecule that targets hard-to-treat cancers by silencing two key genes — KRAS and MYC — while also delivering drugs directly to affected tumors. The post New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes appeared first on UNC Lineberger.
